Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Damh van den Beemt"'
Publikováno v:
Poster Presentations.
Background Neuroblastoma (NBL) is the most common pediatric solid tumor and responsible for about 15% of all pediatric cancer deaths. The majority of high-risk (HR) patients suffers from relapse after intense therapy regimens, resulting in a 5-year s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::becdf76b862009869040f080a2a54867
https://doi.org/10.1136/jitc-2021-itoc8.52
https://doi.org/10.1136/jitc-2021-itoc8.52
Autor:
Cornel AM; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van der Sman L; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van Dinter JT; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Arrabito M; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Center of Pediatric Hematology & Oncology, University of Catania, Catania, Italy., Dunnebach E; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van Hoesel M; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Kluiver TA; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Lopes AP; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Dautzenberg NMM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Dekker L; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van Rijn JM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van den Beemt DAMH; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Buhl JL; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., du Chatinier A; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Barneh F; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Lu Y; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Lo Nigro L; Center of Pediatric Hematology & Oncology, University of Catania, Catania, Italy., Krippner-Heidenreich A; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Sebestyén Z; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Kuball J; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Department of Hematology, UMC Utrecht, Utrecht, The Netherlands., Hulleman E; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Drost J; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Heesch S; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Heidenreich OT; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Peng WC; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Nierkens S; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands S.Nierkens-2@prinsesmaximacentrum.nl.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 21; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 21.
Autor:
Cornel AM; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands., Dunnebach E; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands., Hofman DA; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Das S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; School of Biotechnology, KIIT University, Bhubaneswar, India., Sengupta S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., van den Ham F; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Wienke J; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Strijker JGM; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., van den Beemt DAMH; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands., Essing AHW; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Koopmans B; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Engels SAG; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Lo Presti V; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands., Szanto CS; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., George RE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Molenaar JJ; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., van Heesch S; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Dierselhuis MP; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Nierkens S; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands S.Nierkens-2@prinsesmaximacentrum.nl.; Center for Translational Immunology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Dec; Vol. 10 (12).
Autor:
Lo Presti V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Cutilli A; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Dogariu Y; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Müskens KF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Dünnebach E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van den Beemt DAMH; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Plantinga M; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.
Publikováno v:
The CRISPR journal [CRISPR J] 2022 Jun; Vol. 5 (3), pp. 435-444.
Autor:
Plantinga M; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van den Beemt DAMH; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Dünnebach E; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Nierkens S; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Jul 29; Vol. 13 (15). Date of Electronic Publication: 2021 Jul 29.
Autor:
Szanto CL; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Tamminga SM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Delemarre EM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., de Koning CCH; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., van den Beemt DAMH; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Dunnebach E; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Tas ML; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands., Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands., Tytgat LGAM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Division Imaging and Cancer, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Kraal KCJM; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands., Boelens JJ; Stem Cell Transplantation and Cellular Therapies Program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht University, 3584 CS Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Apr 26; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 26.
Autor:
Plantinga M; Laboratory of Translational Immunology, University Medical Center Utrecht, 3584 XC Utrecht, The Netherlands. m.c.plantinga-2@umcutrecht.nl., de Haar CG; Cell Therapy Facility, Pharmacy Department, University Medical Center Utrecht, 3584 XC Utrecht, The Netherlands. c.g.dehaar@umcutrecht.nl., Dünnebach E; Laboratory of Translational Immunology, University Medical Center Utrecht, 3584 XC Utrecht, The Netherlands. E.dunnebach-2@umcutrecht.nl., van den Beemt DAMH; Laboratory of Translational Immunology, University Medical Center Utrecht, 3584 XC Utrecht, The Netherlands. d.a.m.vandenbeemt@umcutrecht.nl., Bloemenkamp KWM; Division Woman and Baby, Department of Obstetrics, University Medical Center Utrecht, Birth Center Wilhelmina's Children Hospital, 3584 EA Utrecht, The Netherlands. K.W.M.Bloemenkamp@umcutrecht.nl., Mokry M; Division of Pediatrics, University Medical Center Utrecht, 3584 EA Utrecht, The Netherlands. M.Mokry@umcutrecht.nl., Boelens JJ; Laboratory of Translational Immunology, University Medical Center Utrecht, 3584 XC Utrecht, The Netherlands. boelensj@mskcc.org.; Blood and Marrow Transplantation Program, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands. boelensj@mskcc.org.; Stem Cell Transplant and Cellular Therapies, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. boelensj@mskcc.org., Nierkens S; Laboratory of Translational Immunology, University Medical Center Utrecht, 3584 XC Utrecht, The Netherlands. s.nierkens@umcutrecht.nl.; Blood and Marrow Transplantation Program, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands. s.nierkens@umcutrecht.nl.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Feb 05; Vol. 11 (2). Date of Electronic Publication: 2019 Feb 05.